Purnanand D. Sarma's most recent trade in Immunome Inc was a trade of 166,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 8, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Purnanand D. Sarma | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 166,500 | 166,500 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Purnanand D. Sarma | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 121,000 | 121,000 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Purnanand D. Sarma | Director, president and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 93,354 | 93,354 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Purnanand D. Sarma | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.41 per share. | 25 May 2021 | 10,500 | 10,500 | - | 18.4 | 193,305 | Common Stock |